Multi-Omics Prediction of Radiation Lung Injury in Immunotherapy-Treated Lung Cancer Patients

ConditionsLung Cancer (NSCLC)Lung Cancer (SCLC)

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorHAN GUANG

About this trial

This prospective study aims to develop a multi-omics-based predictive model for radiation pneumonitis in lung cancer patients receiving sequential immunotherapy and thoracic radiotherapy.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

No Intervention: Observational Cohort

Treatment groups

160 Participants

are divided into 1 treatment group

Sponsors and collaborators

HAN GUANG

Lead sponsor

Hubei Cancer Hospital

Sponsor institution

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Collaborator

Source ClinicalTrials.gov